SCHEMBL28156720

SCHEMBL28156720

O=C(Nc1ccc(S(=O)(=O)N2CCCCC2)s1)c1ccccc1F

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 9/20 0.64
▸ MEN1 O00255 5/20 0.64
▸ KMT2A Q03164 5/20 0.64
▸ TP53 P04637 2/20 0.64
▸ KDM4E B2RXH2 2/20 0.51
▸ ALDH1A1 P00352 4/20 0.50
▸ HTT P42858 2/20 0.50
▸ POLB P06746 1/20 0.50
▸ USP2 O75604 1/20 0.50
▸ GLA P06280 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ ATM Q13315 1/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ NPC1 O15118 2/20 0.49
▸ RAB9A P51151 2/20 0.49
▸ MCL1 Q07820 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ RXFP1 Q9HBX9 2/20 0.47
▸ LMNA P02545 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28157299 0.88 MAPT (0.66) MAPTMEN1KMT2ATP53ALDH1A1
SCHEMBL28846321 0.84 KMT2A (0.65) MAPTMEN1KMT2ATP53KDM4E
SCHEMBL28157418 0.84 MAPT (0.48) MAPTMEN1KMT2ATP53KDM4E
SCHEMBL28157289 0.82 MAPT (0.61) MAPTMEN1KMT2ATP53KDM4E
SCHEMBL28157420 0.81 MAPT (0.59) MAPTMEN1KMT2ATP53KDM4E
SCHEMBL16337519 0.80 CFTR (0.63) MAPTMEN1KMT2ATP53KDM4E
SCHEMBL28846379 0.80 HPGD (0.52) MAPTMEN1KMT2ATP53HTT
SCHEMBL28156732 0.80 MAPT (0.44) MAPTMEN1KMT2ATP53KDM4E
SCHEMBL28156717 0.80 MEN1 (0.50) MAPTMEN1KMT2ATP53HTT
SCHEMBL16088776 0.78 L3MBTL1 (0.62) MAPTMEN1KMT2ATP53KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105531268-B Noval chemical compound and its pharmaceutical composition for treating cystic fibrosis 加拉佩格斯股份有限公司 2017-09-12 — — CN disclosed
Send feedback